Do you people really not understand what a Phase 1/2 study is??? Why in the world would there be layoffs right now? The trial is still ongoing. In fact according to their website it looks like they're hiring,
The primary endpoint results were pretty bad and confusing to say the least. Vical should not be in charge of designing trials anymore. The only thing they have going for them is that Vaxfectin works and that Astellas is conducting the Phase 3 CMV trials themself. Vical should just be focused on licensing out Vaxfectin and be happy just collecting royalties from the big pharmas that know what they're doing. Well atleast the antifungal drug was already designed by Astellas before they sold it to Vical so maybe that will have a chance too.